Tekla Capital Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Tekla Capital Management’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-214,845	Closed	-$1.05M	–	217
2019 Q3	$1.05M	Hold	214,845	–	–	0.05%	157
2019 Q2	$1.31M	Hold	214,845	–	–	0.05%	155
2019 Q1	$1.25M	Sell	214,845 -290,856	-58%	-$3M	0.05%	148
2018 Q4	$6.81M	Buy	505,701 +66,700	+15%	+$1.12M	0.29%	67
2018 Q3	$8.52M	Hold	439,001	–	–	0.31%	71
2018 Q2	$11.2M	Hold	439,001	–	–	0.43%	54
2018 Q1	$8.85M	Sell	439,001 -201,491	-31%	-$4.7M	0.34%	67
2017 Q4	$12.9M	Buy	640,492 +178,780	+39%	+$3.52M	0.5%	44
2017 Q3	$9.56M	Hold	461,712	–	–	0.34%	54
2017 Q2	$6.83M	Buy	461,712 +331,489	+255%	+$5.52M	0.25%	76
2017 Q1	$2.08M	Hold	130,223	–	–	0.08%	111
2016 Q4	$1.64M	Buy	130,223 +43,060	+49%	+$802K	0.07%	114
2016 Q3	$2.44M	Buy	+87,163	New	+$2.92M	0.09%	111

Other funds holding DPLO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

OAC

OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Tekla Capital Management's DPLO Position: Q4 2019 in Review

Tekla Capital Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2019, closing a stake of 214,845 shares — an estimated $1.05M sold.

Tekla Capital Management first reported a position in DPLO in Q3 2016 and held it in 13 quarters. The position peaked at $12.9M in Q4 2017. 138 funds tracked by Wall St. Rank hold DPLO as of Q4 2019.

Tekla Capital Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2019 after selling out during the quarter.
Tekla Capital Management sold 214,845 DIPLOMAT PHARMACY, INC. shares in Q4 2019, an estimated $1.05M.
Tekla Capital Management first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2016 and held it in 13 quarters.
Tekla Capital Management's DIPLOMAT PHARMACY, INC. position peaked at $12.9M in Q4 2017.
138 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2019.

Based on Tekla Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.